Hyperhomocysteinemia (hypHcy) has been shown to promote apoptosis of RGCs [8], which in turn is a result of reduction in the activity of an enzyme 5,10-methylenetetrahydofolate reductase (MTHFR, EC 1.5.1.20). The gene discussed is MTHFR; the disease is hyperhomocysteinemia.